Authors
Latest:
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes MellitusWe examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
Latest:
Another Look at Failed Alzheimer Disease Drug TrialThe exact etiology of Alzheimer's is unknown, and therefore, no cure exists.
Latest:
Clozapine: A Primer For PharmacistsClozapine is an atypical antipsychotic for the treatment of schizophrenia.
Latest:
Key Takeaways from Asembia 2018The annual Asembia Specialty Pharmacy Summit is the largest annual conference in the United States focused on specialty the specialty space.
Latest:
Specialty Pharmacy: Increasing Value Through Accountability and CollaborationThis dynamic market is seeing a lot of growth, changes, and challenges. Specialty pharmacists can tackle the tough issues and raise the bar on greater levels of efficiency, accountability, and service while curtailing costs.
Latest:
Being Critical as a Critical Care PharmacistCritical care is a rapidly expanding pharmacy specialty, and today's pharmacy student have more opportunities than ever to bceome successful critical care pharmacist.
Latest:
Unique Considerations for Specialized Patient Populations for Pharmacies Utilizing Appointment-Based Care Models: Part 2While there is a reasonable body of research on many of the diverse causes of medication nonadherence, there are much fewer data on the effectiveness of various interventions.
Latest:
Biosimilars May Change the Treatment Landscape for Inflammatory DiseasesClinician and patient understanding and access considerations represent the most significant hurdles inhibiting the uptake of biosimilars for inflammatory conditions.
Latest:
UnitedHealthcare Bars Copay Coupons for Specialty DrugsAccording to a report by Elsevier's Business Intelligence, UnitedHealthcare has announced that pharmacies that are participating in its Designated Specialty Pharmacy network will no longer redeem manufacturer-sponsored coupons.
Latest:
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial FibrillationThis study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Latest:
What You Need to Know about Hot Tamales CandyBenzidine-based dyes commonly used in pharmaceuticals are also found in popular candy, which may lead to adverse health issues.
Latest:
Specialty Pharmacy By the NumbersAs specialty pharmacies continue to grow, health systems will need to evaluate whether an integrated specialty pharmacy is right for them.
Latest:
Rx Product News Profile: A Closer Look at New FDA Actions: Bristol-Myers Squibb's and AstraZeneca's OnglyzaOnglyza (saxagliptin) comarketed by Bristol-Myers Squibb and AstraZeneca, is FDA-approved to improve glycemic control for the treatment of type 2 diabetes.
Latest:
Pharmacists Need to Understand Law Related to Controlled SubstancesThe Protecting Patient Access to Emergency Medications Act of 2017 Spells Out Appropriate Dispensing Procedures.
Latest:
Many Platforms Offer Rapid Detection in Bloodstream InfectionsInstitutions should consider optimal targets, testing volumes, and notification and reporting practices when making their choice.
Latest:
Inconsistent Prior Authorization Affects Attention-Deficit/Hyperactivity Disorder TreatmentStudy finds that ADHD treatment recommendations are not always followed.
Latest:
Pharmacogenetic Resources: PharmGKB and Clinical Pharmacogenetics Implementation ConsortiumPharmacogenetics is the study of how genes impact drug response, an integral part of personalized medicine.
Latest:
Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes MellitusIn outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Latest:
Zuranolone Offers An Innovative Treatment for Postpartum DepressionZuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
Estrogens and Lamotrigine: New DevelopmentsPractitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.
Latest:
Treatments for Tardive Dyskinesia: What Pharmacists Should KnowThere are two recently approved medications for this condition.
